Enforcement Trends: OIG Calls Out CMS for Not Preventing Medicare Genetic Testing Overpayments
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
From - G2 Compliance Advisor
Reiterating its longstanding aversion to labs providing free items or services to referral sources, the Department of Health & Human Services Office of Inspector General (OIG) issued an…
From - National Intelligence Report
The OIG's latest semiannual report to Congress as usual touts its successes with oversight and enforcement and provides a guide to…
From - National Intelligence Report
There are few surprises in the Health and Human Services Office of Inspector General's 2017 Work Plan. The OIG's annual Work Plan provides…
From - National Intelligence Report
Oct. 15, 2016 marks 40 years since the U.S. Department of Health & Human Services (HHS) Office of Inspector General (OIG) was launched in…
From - National Intelligence Report
Facing the uncertainty of trial, Continuum has officially settled reverse false claims allegations for…
From - National Intelligence Report
An Office of Inspector General report detailing results of 2015 enforcement efforts by the Senior Medicare Patrol (SMP) show success but not overwhelming recoveries. However, the report cautions that…